SB

Shantinath Bhupal Patil

Director Partner DIN 09276838
DIN 09276838 First appointment Aug 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2021
Shareholding value •••• Premium profile

About Shantinath Bhupal Patil

Data last updated:

Shantinath Bhupal Patil was a Partner at Futurestic Medicines Llp (2022–2025) and Additional Director at Nextwonder Pharma Private Limited (2021–2022). The companies operate in Chemicals and Pharma.

DIN 09276838
Primary Designation Partner
Industry Chemicals
First Appointment 11 Aug 2021

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Partner04 May 20222022Active
Nextwonder Pharma Private Limited U24239PN2021PTC199484
Additional Director11 Aug 20212021₹1.12 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Futurestic Medicines Llp
Nextwonder Pharma Private Limited
Premium access

Shareholding and investment profile for Shantinath Bhupal Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shantinath Bhupal Patil

Shantinath Bhupal Patil was first appointed on 11 Aug 2021 as Additional Director at Nextwonder Pharma Private Limited. The most recent appointment on record is 04 May 2022 at Futurestic Medicines Llp.

Shantinath Bhupal Patil held 2 earlier board appointments: Futurestic Medicines Llp (Partner, 04 May 2022 to 12 Jun 2025); Nextwonder Pharma Private Limited (Additional Director, 11 Aug 2021 to 30 Dec 2022).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available